Charles Ginther

528 total citations
6 papers, 430 citations indexed

About

Charles Ginther is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Charles Ginther has authored 6 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Charles Ginther's work include HER2/EGFR in Cancer Research (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer-related gene regulation (2 papers). Charles Ginther is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer-related gene regulation (2 papers). Charles Ginther collaborates with scholars based in United States and Japan. Charles Ginther's co-authors include Dennis J. Slamon, Juri Kim, Seyung Chung, Yanyuan Wu, Jaydutt V. Vadgama, William D. Tap, Hong Wu, Lee Anderson, Frederick R. Eilber and Fritz C. Eilber and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Epidemiology Biomarkers & Prevention and Neoplasia.

In The Last Decade

Charles Ginther

6 papers receiving 425 citations

Peers

Charles Ginther

MB

ONCOL

CR

PRM

PFM

Jason P.W. Carey United States

Kelly E. Craven United States

Søren M. Johnson United States

Christophe Severin United States

Hanne Puntervoll Norway

Karl Hsu United States

Soonweng Cho United States

Anthony G. Clementz United States

Tim Nichols United States

Jennifer R. Stephens United States

Jason P.W. Carey United States

Charles Ginther

386 ×1.3

MB

307 ×1.5

ONCOL

101 ×1.0

CR

111 ×1.1

PRM

30 ×0.5

PFM

Citations per year, relative to Charles Ginther Charles Ginther (= 1×) peers Jason P.W. Carey

Countries citing papers authored by Charles Ginther

Since Specialization

Citations

This map shows the geographic impact of Charles Ginther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Ginther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Ginther more than expected).

Fields of papers citing papers by Charles Ginther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Ginther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Ginther. The network helps show where Charles Ginther may publish in the future.

Co-authorship network of co-authors of Charles Ginther

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Ginther. A scholar is included among the top collaborators of Charles Ginther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Ginther. Charles Ginther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wu, Yanyuan, Charles Ginther, Juri Kim, et al.. (2012). Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells. Molecular Cancer Research. 10(12). 1597–1606. 208 indexed citations

2.

Wu, Yanyuan, Charles Ginther, Juri Kim, et al.. (2012). Abstract B31: Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab resistant HER2-overexpressing breast cancer cells.. Cancer Epidemiology Biomarkers & Prevention. 21(10_Supplement). B31–B31. 2 indexed citations

3.

Tap, William D., Charles Ginther, Giovanni M. Pauletti, et al.. (2010). Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma. Neoplasia. 12(8). 637–IN3. 71 indexed citations

4.

Tap, William D., Fritz C. Eilber, Charles Ginther, et al.. (2010). Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization. Genes Chromosomes and Cancer. 50(2). 95–112. 83 indexed citations

5.

Tap, William D., Judy Dering, Charles Ginther, et al.. (2010). Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in. 3 indexed citations

6.

Walsh, Christine, Seishi Ogawa, Hisae Karahashi, et al.. (2008). ERCC5 Is a Novel Biomarker of Ovarian Cancer Prognosis. Journal of Clinical Oncology. 26(18). 2952–2958. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact